Gelteq limited ordinary sharesGELS.US Overview

US StockHealthcare

(No presentation for GELS)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

GELS Overall Performance

GELS AI Analysis & Strategy

GELS Recent Performance

-12.30%

Gelteq limited ordinary shares

0.81%

Avg of Sector

-1.14%

S&P500

GELS PowerScanner

GELS Key Information

GELS Valuation Metrics

GELS Earnings Table

GELS Profile

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.